NeuroPace director granted shares and stock options

NeuroPace Inc director Rakhi Kumar received new equity awards.

Rhea-AI Filing Summary

NeuroPace Inc director Rakhi Kumar received new equity awards. On the reported date, Kumar was granted 2,890 shares of common stock at no purchase price, increasing direct holdings to 22,050 shares.

Kumar was also granted stock options for 5,368 shares of common stock at an exercise price of $15.74, expiring in 2036. Both the stock and option grants vest in twelve equal monthly installments, contingent on continued service through each vesting date.

Insider Trade Summary

Grant/Award: 8,258 shares

Grant/Award 2 txns

Insider Kumar Rakhi

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	5,368	$0.00	$0.00
Grant/Award	Common Stock	2,890	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 5,368 contracts (Direct); Common Stock — 22,050 shares (Direct)

Footnotes (2)

1. F1. The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.
2. F2. The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.

Key Figures

Common shares granted: 2,890 shares Shares held after grant: 22,050 shares Options granted: 5,368 options +3 more

6 metrics

Common shares granted 2,890 shares Director equity award on transaction date

Shares held after grant 22,050 shares Common stock directly owned after transaction

Options granted 5,368 options Stock Option (Right to Buy) on common stock

Option exercise price $15.74 per share Strike price for 5,368-stock-option grant

Option expiration 2036-06-04 Expiration date for stock options

Vesting schedule 12 monthly installments Applies to both share and option grants, service-based

Key Terms

Stock Option (Right to Buy), exercise price, vesting, continuous service, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

exercise price financial

"conversion_or_exercise_price: "15.7400""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The shares shall vest in twelve (12) equal consecutive monthly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

continuous service financial

"subject to the Reporting Person's continuous service through each vesting date"

fully vested and exercisable financial

"until all of the option shares are fully vested and exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did NeuroPace (NPCE) director Rakhi Kumar report in this Form 4?

Rakhi Kumar reported receiving 2,890 NeuroPace common shares and stock options for 5,368 shares as equity compensation. These awards are part of routine director compensation and are not open-market purchases or sales of stock.

How many NeuroPace (NPCE) shares does Rakhi Kumar hold after the reported grant?

After the grant, Rakhi Kumar directly holds 22,050 NeuroPace common shares. This reflects the addition of 2,890 granted shares, which were awarded at no purchase price as part of director equity compensation disclosed in the Form 4 filing.

What are the terms of the NeuroPace (NPCE) stock options granted to Rakhi Kumar?

Kumar received stock options for 5,368 NeuroPace common shares with a $15.74 exercise price. The options expire in 2036 and vest in twelve equal monthly installments, subject to Kumar’s continuous service through each vesting date.

Are Rakhi Kumar’s NeuroPace (NPCE) equity awards immediately vested?

No, the equity awards vest over time. The 2,890 common shares and 5,368 option shares each vest in twelve equal monthly installments, contingent on Rakhi Kumar’s continuous service with NeuroPace through each scheduled vesting date.

Does this NeuroPace (NPCE) Form 4 show any stock sales by Rakhi Kumar?

No, the filing reports only equity grants to Rakhi Kumar and no stock sales. It shows acquisitions of common shares and stock options as compensation, with no open-market buying or selling activity disclosed in this particular Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 05:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kumar Rakhi

(Last) (First) (Middle)

C/O NEUROPACE, INC.

455 N. BERNARDO AVENUE

(Street)

MOUNTAIN VIEW CALIFORNIA 94043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NeuroPace Inc [ NPCE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		A		2,890(1)	A	$0	22,050	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$15.74	06/05/2026		A		5,368		(2)	06/04/2036	Common Stock	5,368	$0	5,368	D

Explanation of Responses:

1. The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.

2. The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.

Remarks:

	/s/ Leah Akin, Attorney-in-Fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)